Karyotype evolution of multiple myeloma
Journal of Clinical and Experimental Hematopathology · 2026 · 66 (1) · 19-26
DOI: 10.3960/jslrt.25086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Yosuke Matsumoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Multiple Myeloma, Karyotype, Chromosome Aberrations, Evolution, Molecular. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
- Chromosome, Cellular Immunology Analysis Department, SRL, Inc., Tokyo, Japan.
Zitieren
APA
Matsumoto, Y., Ichimura, T., Harukawa, J., Fujioka, K., Suzuki, H., Nonaka, K., Muramatsu, A., Sugitani, M., Kobayashi, T., Iwai, T., & Uchiyama, H. (2026). Karyotype evolution of multiple myeloma. Journal of Clinical and Experimental Hematopathology, 66(1), 19-26. https://doi.org/10.3960/jslrt.25086
Vancouver
Matsumoto Y, Ichimura T, Harukawa J, Fujioka K, Suzuki H, Nonaka K, et al. Karyotype evolution of multiple myeloma. Journal of Clinical and Experimental Hematopathology. 2026;66(1):19-26. doi:10.3960/jslrt.25086
BibTeX
@article{Matsumoto2026,
author = {Matsumoto, Yosuke and Ichimura, Tsuyoshi and Harukawa, Junichi and Fujioka, Kozue and Suzuki, Harunori and Nonaka, Koichi and Muramatsu, Ayako and Sugitani, Mio and Kobayashi, Tsutomu and Iwai, Toshiki and Uchiyama, Hitoji},
title = {Karyotype evolution of multiple myeloma},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2026},
volume = {66},
number = {1},
pages = {19--26},
doi = {10.3960/jslrt.25086}
}
EUVIMED